Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Strong Life-Sciences Growth Buoys Bruker Daltonics Bottom Line

NEW YORK, May 6 - Bruker Daltonics today reported that strong first-quarter growth in its life-sciences business helped boost total revenue despite static or declining performance from other units.


Total revenue in the period ended March 31 grew to $25.7 million from $21.9 million one year ago. Of the company's total product revenues, life science systems accounted for 76 percent, up from 70 percent a year ago, Bruker said. Its substance-detection and aftermarket revenues represent 8 percent and 16 percent of product revenues this year, respectively, compared with 8 percent and 22 percent year over year.


R&D spending in the first quarter 2002 remained relatively flat at $4.5 million compared with $4.6 million reported during the same period one year ago. Total first-quarter costs and operating expenses, though, grew to $24.4 million from $21.2 million year over year.


Bruker also reported a dip in first-quarter net income to $941,000, or $.02 per share, compared with $945,000, or $.02 per share, in the first quarter 2001.


The company said it had $66.8 million in cash and short-term investments as of March 31, a slight drop from the $70.1 million it had as of Dec. 31, 2001.


For more information, click here.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.